Fatma K. Sen

Ueskuedar, 34768, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

Journal: Cancers
Published: May 12, 2026

Investigation of clinicopathological and prognostic association of TERT promoter mutation in non-small cell lung cancer in a Turkish population.

Investigation of clinicopathological and prognostic association of TERT promoter mutation in non-small cell lung cancer in a Turkish population.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists
Published: August 04, 2025

Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings.

Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings.

Journal: Molecular imaging and radionuclide therapy
Published: February 07, 2025

Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.

Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.

Journal: BMC cancer
Published: August 15, 2024

Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.

Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.

Journal: Pathology, research and practice
Published: August 25, 2023

Effect of Cytotoxic Therapy on ALU Expression is Modulated by Hormonal Status in Patients with Breast Cancer

Effect of Cytotoxic Therapy on ALU Expression is Modulated by Hormonal Status in Patients with Breast Cancer

Journal: Balkan medical journal
Published: October 07, 2022

Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.

Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.

Journal: Cancer biomarkers : section A of Disease markers
Published: October 24, 2019

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients.

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients.

Journal: Florence Nightingale journal of nursing
Published: June 17, 2019

Interleukin-10 is increased in successful drug desensitization regardless of the hypersensitivity reaction type.

Interleukin-10 is increased in successful drug desensitization regardless of the hypersensitivity reaction type.

Journal: Asia Pacific allergy
Published: September 19, 2018

High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated/dedifferentiated carcinomas of the endometrium: An immunohistochemical and clinicopathologic study.

High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated/dedifferentiated carcinomas of the endometrium: An immunohistochemical and clinicopathologic study.

Journal: Medicine
Published: March 09, 2017

BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.

BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.

Journal: Pathology
Published: August 08, 2016

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Journal: Medicine
Published: July 30, 2016
Showing 1-12 of 55

Last Updated: 09/26/2026